Indian Army Department Of Military Affairs Pharmaceutical & Medical Consumables Tender 2025
Indian Army
Bid Publish Date
07-Nov-2024, 6:35 pm
Bid End Date
28-Nov-2024, 7:00 pm
Progress
Quantity
39919
Category
E RE 43 Insulin Lispro Biphasic inj I dot P 25 Insulin Lispro and 75 Insulin Lispron protamine suspension
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army E RE 43 Insulin Lispro Biphasic inj I dot P 25 Insulin Lispro and 75 Insulin Lispron protamine suspension, E RE 43 Tab Solifenacin 5 mg, E RE 43 Calcium acetate 500 mg Tab, E RE 43 Tacrolimus 1mg Tab, E RE 43 Tacrolimus 0 dot 5mg Cap, E RE 43 Sevelamer 400 mg Tab, E RE 43 Gatifloxacin 0 dot 3 eye drop Bott of 5 ml, E RE 43 Ketorolac Tromethamine 0 dot 4 Eye drops, E RE 43 Brimonidine Tartrate 0 dot 2 Eye drops, E RE 43 Carboxy Methyl Cellulose CMC 1 Gel, E RE 43 Pilocarpine Nitrate eye solution 2 bott of 5 ml, E RE 43 Pilocarpine Intracameral Inj 0 dot 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each, E RE 43 Povidone 5 eye drop bott of 5 ml, E RE 43 Azelaic acid 20 cream tube of 15 gm, E RE 43 Timolol Maleate eye drop 0 dot 5 Bott of 5 ml, E RE 43 Atropine sulphate 1 w v bott of 3 ml, E RE 43 Bimatoprost 0 dot 03 Bott of 3ml, E RE 43 Dorzolamide 2 plus Timolol 0 dot 5 bott of 5 ml, E RE 43 Olopatadine 0 dot 2 Ophthalmic Soln bott of 5 ml, E RE 43 Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg, E RE 43 Betahistine 16 mg Tab, E RE 43 Cinnarizine 25 mg Tab, E RE 43 Prochlorperazine Maleate 5mg Tab, E RE 43 Cypropheptadine HCl 2 mg 5ml Bott of 100 ml, E RE 43 Syp Azythromycin 200 mg 15 ml Bott, E RE 43 Metronidazole susp 200 mg 5ml Bott of 60 ml, E RE 43 Ondansetron Syp 2 mg 5ml in Bott of 30 ml, E RE 43 Chloridiazepoxide 10mg Tab, E RE 43 Clonazepam 0 dot 5 mg Tab, E RE 43 Fluoxetine HCl 20 mg Cap, E RE 43 Haloperidol 5 mg Tab, E RE 43 Lorazepam 1 mg Tab. Quantity: 39919 issued by. Submission Deadline: 28-11-2024 19: 00: 00. View full details and respond.
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Indian Army
PATIALA, PUNJAB
Dg Armed Forces Medical Service
JHANSI, UTTAR PRADESH
Dg Armed Forces Medical Service
GURDASPUR, PUNJAB
Indian Air Force
JORHAT, ASSAM
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | E RE 43 Insulin Lispro Biphasic inj I dot P 25 Insulin Lispro and 75 Insulin Lispron protamine suspension | Insulin Lispro Biphasic inj I.P (25% Insulin Lispro and 75% Insulin Lispron protamine suspension | 21 | pfp pfs | vivek2022 | 30 |
| 2 | E RE 43 Tab Solifenacin 5 mg | Tab Solifenacin 5 mg | 3,700 | no | vivek2022 | 30 |
| 3 | E RE 43 Calcium acetate 500 mg Tab | Calcium acetate 500 mg Tab | 5,300 | no | vivek2022 | 30 |
| 4 | E RE 43 Tacrolimus 1mg Tab | Tacrolimus 1mg Tab | 1,700 | no | vivek2022 | 30 |
| 5 | E RE 43 Tacrolimus 0 dot 5mg Cap | Tacrolimus 0.5mg Cap | 1,700 | no | vivek2022 | 30 |
| 6 | E RE 43 Sevelamer 400 mg Tab | Sevelamer 400 mg Tab | 7,600 | no | vivek2022 | 30 |
| 7 | E RE 43 Gatifloxacin 0 dot 3 eye drop Bott of 5 ml | Gatifloxacin 0.3% eye drop Bott of 5 ml | 7 | bott | vivek2022 | 30 |
| 8 | E RE 43 Ketorolac Tromethamine 0 dot 4 Eye drops | Ketorolac Tromethamine 0.4%, Eye drops | 30 | bott | vivek2022 | 30 |
| 9 | E RE 43 Brimonidine Tartrate 0 dot 2 Eye drops | Brimonidine Tartrate 0.2%, Eye drops | 120 | bott | vivek2022 | 30 |
| 10 | E RE 43 Carboxy Methyl Cellulose CMC 1 Gel | Carboxy Methyl Cellulose (CMC) 1%, Gel | 150 | bott | vivek2022 | 30 |
| 11 | E RE 43 Pilocarpine Nitrate eye solution 2 bott of 5 ml | Pilocarpine Nitrate eye solution 2% bott of 5 ml | 15 | bott | vivek2022 | 30 |
| 12 | E RE 43 Pilocarpine Intracameral Inj 0 dot 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each | Pilocarpine Intracameral Inj 0.5% Pilocarpine nitrate intra-ocular Initrate intra ocular Inj without preservatives amp of 01ml each | 60 | amp vial | vivek2022 | 30 |
| 13 | E RE 43 Povidone 5 eye drop bott of 5 ml | Povidone 5% eye drop bott of 5 ml | 80 | bott | vivek2022 | 30 |
| 14 | E RE 43 Azelaic acid 20 cream tube of 15 gm | Azelaic acid 20% cream, tube of 15 gm | 3 | tube | vivek2022 | 30 |
| 15 | E RE 43 Timolol Maleate eye drop 0 dot 5 Bott of 5 ml | Timolol Maleate eye drop 0.5% Bott of 5 ml | 80 | bott | vivek2022 | 30 |
| 16 | E RE 43 Atropine sulphate 1 w v bott of 3 ml | Atropine sulphate 1% w/v bott of 3 ml | 5 | bott | vivek2022 | 30 |
| 17 | E RE 43 Bimatoprost 0 dot 03 Bott of 3ml | Bimatoprost 0.03% Bott of 3ml | 100 | bott | vivek2022 | 30 |
| 18 | E RE 43 Dorzolamide 2 plus Timolol 0 dot 5 bott of 5 ml | Dorzolamide 2% + Timolol 0.5%, bott of 5 ml | 60 | bott | vivek2022 | 30 |
| 19 | E RE 43 Olopatadine 0 dot 2 Ophthalmic Soln bott of 5 ml | Olopatadine 0.2% Ophthalmic Soln, bott of 5 ml | 50 | bott | vivek2022 | 30 |
| 20 | E RE 43 Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg | Syp Diphenhydramine 10-15 mg per 5 ml and Ammonium Chloride 100 -150 mg,Sodium Citrate 50-85 mg per 5 ml Bottle of 100 ml | 400 | bott | vivek2022 | 30 |
| 21 | E RE 43 Betahistine 16 mg Tab | Betahistine 16 mg Tab | 8,200 | no | vivek2022 | 30 |
| 22 | E RE 43 Cinnarizine 25 mg Tab | Cinnarizine 25 mg Tab | 700 | no | vivek2022 | 30 |
| 23 | E RE 43 Prochlorperazine Maleate 5mg Tab | Prochlorperazine Maleate 5mg Tab | 900 | no | vivek2022 | 30 |
| 24 | E RE 43 Cypropheptadine HCl 2 mg 5ml Bott of 100 ml | Cypropheptadine HCl 2 mg/5ml Bott of 100 ml | 45 | bott | vivek2022 | 30 |
| 25 | E RE 43 Syp Azythromycin 200 mg 15 ml Bott | Syp Azythromycin 200 mg / 15 ml Bott | 15 | bott | vivek2022 | 30 |
| 26 | E RE 43 Metronidazole susp 200 mg 5ml Bott of 60 ml | Metronidazole susp 200 mg/5ml Bott of 60 ml | 9 | bott | vivek2022 | 30 |
| 27 | E RE 43 Ondansetron Syp 2 mg 5ml in Bott of 30 ml | Ondansetron Syp 2 mg/5ml in Bott of 30 ml | 9 | bott | vivek2022 | 30 |
| 28 | E RE 43 Chloridiazepoxide 10mg Tab | Chloridiazepoxide 10mg Tab | 2,600 | no | vivek2022 | 30 |
| 29 | E RE 43 Clonazepam 0 dot 5 mg Tab | Clonazepam 0.5 mg Tab | 5,000 | no | vivek2022 | 30 |
| 30 | E RE 43 Fluoxetine HCl 20 mg Cap | Fluoxetine HCl 20 mg Cap | 800 | no | vivek2022 | 30 |
| 31 | E RE 43 Haloperidol 5 mg Tab | Haloperidol 5 mg Tab | 200 | no | vivek2022 | 30 |
| 32 | E RE 43 Lorazepam 1 mg Tab | Lorazepam 1 mg Tab | 260 | no | vivek2022 | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
The eligibility requirements include being a registered entity with proven experience in supplying pharmaceutical products. Additionally, bidders must provide documentation to demonstrate compliance with any applicable experience criteria, including OEM authorization where needed.
Bidders need to present several required certificates, including an OEM authorization certificate, proof of past performance, and a turnover certificate as outlined in the tender document.
To participate, bidders must register on the GeM Portal where they can create an account, complete all required profiles, and submit their proposals and relevant documents.
Only specific accepted document formats are permitted for submissions, commonly including PDF and other clearly defined formats stipulated in the bid document. Bidders should verify the requirements listed in the document.
The technical specifications encompass a range of quality standards ensuring the efficacy and safety of medicines. These are detailed in the BOQ document linked in the tender.
All products must adhere to quality standards defined by pharmaceutical regulatory authorities. Compliance with these standards is crucial in the evaluation process.
Suppliers must fulfill various compliance requirements pertaining to pharmaceutical regulations, quality certifications, and specifications as listed in the tender document.
The Earnest Money Deposit (EMD) serves to secure the bid process and must be submitted as part of the financial proposal. Specific amounts and payment methods are detailed in the tender documentation.
Yes, a performance security may be required to ensure compliance with contract terms upon award of the project. Details regarding the amount and conditions for such security are specified in the tender.
The payment terms for successful bidders will generally revolve around the delivery of goods and may include milestones or net payment terms post-delivery verification as per specified contractual arrangements.
Price evaluation considerations focus on both the bid amount and the technical compliance of items offered. bids will typically prioritize the lowest priced technically qualified offerings.
Bidders must submit their proposals through the GeM Portal, ensuring adherence to submission guidelines and including all required documentation as specified.
High-level key timelines and deadlines, including bid submission and opening times, can be found in the main bid document. It is crucial to adhere to these dates to ensure participation.
The evaluation and selection process involves a thorough review of both technical qualifications and price, aiming to select the best-fit supplier based on established criteria.
Bidders will receive notifications regarding the outcomes via the GeM Portal, including details on the acceptance or rejection of their proposals based on the evaluation results.
MSEs enjoy certain benefits, including potentially relaxed eligibility requirements and preferential treatment to encourage their participation in public procurement initiatives within the pharmaceutical sector.
Yes, there are tailored provisions for startups, promoting their inclusion in public tenders. Specific criteria and relaxations are detailed within the tender documentation.
This tender complies with 'Make in India' policies, prioritizing local manufacturing and procurement rules to bolster the domestic pharmaceutical sector and encourage indigenous production capabilities.
Sign up now to access all documents
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS